971 research outputs found
Impact of multileaf collimator configuration parameters on the dosimetric accuracy of 6-MV Intensity-Modulated radiation therapy treatment plans
The purpose of this study was to evaluate the impact of selected configuration parameters that govern multileaf collimator (MLC) transmission and rounded leaf offset in a commercial treatment planning system (TPS) (Pinnacle3, Philips Medical Systems, Andover, MA, USA) on the accuracy of intensity-modulated radiation therapy (IMRT) dose calculation. The MLC leaf transmission factor was modified based on measurements made with ionization chambers. The table of parameters containing rounded-leaf-end offset values was modified by measuring the radiation field edge as a function of leaf bank position with an ionization chamber in a scanning water-tank dosimetry system and comparing the locations to those predicted by the TPS. The modified parameter values were validated by performing IMRT quality assurance (QA) measurements on 19 gantry-static IMRT plans. Planar dose measurements were performed with radiographic film and a diode array (MapCHECK2) and compared to TPS calculated dose distributions using default and modified configuration parameters. Based on measurements, the leaf transmission factor was changed from a default value of 0.001 to 0.005. Surprisingly, this modification resulted in a small but statistically significant worsening of IMRT QA gamma-index passing rate, which revealed that the overall dosimetric accuracy of the TPS depends on multiple configuration parameters in a manner that is coupled and not intuitive because of the commissioning protocol used in our clinic. The rounded leaf offset table had little room for improvement, with the average difference between the default and modified offset values being -0.2 ± 0.7 mm. While our results depend on the current clinical protocols, treatment unit and TPS used, the methodology used in this study is generally applicable. Different clinics could potentially obtain different results and improve their dosimetric accuracy using our approach
Characterizing the spatial mismatch between intimate partner violence related healthcare services and arrests in Miami-Dade County, Florida
Abstract
Background
Routine screening and intervention for intimate partner violence (IPV) in healthcare settings constitutes an important secondary prevention strategy for identifying individuals experiencing IPV early and connecting them with appropriate services. Considerable variation in available IPV-related healthcare services exists and interventions are needed to improve the quality of these services. One way to prioritize intervention efforts is by examining the level of services provided in communities most at risk relative to local incidence or prevalence of IPV. To inform future interventions, this study examined the spatial relationship between IPV-related healthcare services and IPV arrests in Miami-Dade County, Florida, and identified predictors of the observed spatial mismatch.
Methods
Survey data collected in 2014 from 278 health facilities pertaining to IPV services were geocoded, computed into a density layer, and aggregated at the census tract level to create a population-based normalized comprehensiveness score (NCS) as a proxy for IPV-related healthcare resources. IPV arrests from 2011 to 2015, collected from the county court, were geocoded and summarized by census tracts to serve as a proxy for IPV prevalence. These measures were combined into a resource disparity score (RDS) that compared relative service density to relative arrest rates, where positive RDS represented over-resourced neighborhoods and negative RDS corresponded to under-resourced neighborhoods. We used correlation analyses and a two-phase spatial modeling approach to evaluate correlates of NCS and RDS.
Results
A spatial lag model did not yield an association between NCS and IPV arrests, demonstrating a spatial mismatch, which we visualized using a Geographic Information System (GIS). A spatial error model revealed that the percentage of white non-Hispanic residents was positively associated with RDS, while percent black non-Hispanic, median age, ethnic heterogeneity, and economic disadvantage were negatively associated with RDS.
Conclusions
These findings underscore the need to further evaluate the adequacy of IPV-related healthcare resources for secondary prevention relative to local IPV arrest rates, particularly within economically disadvantaged neighborhoods. Our approach demonstrates the utility of GIS for identifying potential priority regions for IPV prevention efforts and resource allocation
ECO-ROUTE
Capstone Design and Manufacturing Experience: Fall 2006Currently, there are many computer based navigation programs on the market. These mapping programs give the user a route based on the shortest distance from beginning to end point, or fastest time of travel. The Eco-Route project seeks to design a navigation system to find the most fuel efficient route from point A to B. After testing and validation, Eco-Route is capable of determining gas consumption for a specific route within 10% of actual. From our highway and urban routes, we generated an accurate efficiency curve that applies to a specific time of day. These findings were validated for both routes by using our model to predict fuel consumption for each route and then physically driving the route.Professor Steven Skerlos, University of Michigan.
ME 450http://deepblue.lib.umich.edu/bitstream/2027.42/49555/2/ME450 Final Team 19.pd
Great Tit (<i>Parus major</i>) Uropygial Gland Microbiomes and Their Potential Defensive Roles
Mid-infrared fiber-coupled supercontinuum spectroscopic imaging using a tapered chalcogenide photonic crystal fiber
NAADP mobilizes Ca2+ from a thapsigargin-sensitive store in the nuclear envelope by activating ryanodine receptors
Ca2+ release from the envelope of isolated pancreatic acinar nuclei could be activated by nicotinic acid adenine dinucleotide phosphate (NAADP) as well as by inositol 1,4,5-trisphosphate (IP3) and cyclic ADP-ribose (cADPR). Each of these agents reduced the Ca2+ concentration inside the nuclear envelope, and this was associated with a transient rise in the nucleoplasmic Ca2+ concentration. NAADP released Ca2+ from the same thapsigargin-sensitive pool as IP3. The NAADP action was specific because, for example, nicotineamide adenine dinucleotide phosphate was ineffective. The Ca2+ release was unaffected by procedures interfering with acidic organelles (bafilomycin, brefeldin, and nigericin). Ryanodine blocked the Ca2+-releasing effects of NAADP, cADPR, and caffeine, but not IP3. Ruthenium red also blocked the NAADP-elicited Ca2+ release. IP3 receptor blockade did not inhibit the Ca2+ release elicited by NAADP or cADPR. The nuclear envelope contains ryanodine and IP3 receptors that can be activated separately and independently; the ryanodine receptors by either NAADP or cADPR, and the IP3 receptors by IP3
Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.
BACKGROUND: Although many women treated with psychotropic medication become pregnant, no psychotropic medication has been licensed for use in pregnancy. This leaves women and their health-care professionals in a treatment dilemma, as they need to balance the health of the woman with that of the unborn child. The aim of this project was to investigate the risks and benefits of psychotropic medication in women treated for psychosis who become pregnant. OBJECTIVE(S): (1) To provide a descriptive account of psychotropic medication prescribed before pregnancy, during pregnancy and up to 15 months after delivery in UK primary care from 1995 to 2012; (2) to identify risk factors predictive of discontinuation and restarting of lithium (multiple manufacturers), anticonvulsant mood stabilisers and antipsychotic medication; (3) to examine the extent to which pregnancy is a determinant for discontinuation of psychotropic medication; (4) to examine prevalence of records suggestive of adverse mental health, deterioration or relapse 18 months before and during pregnancy, and up to 15 months after delivery; and (5) to estimate absolute and relative risks of adverse maternal and child outcomes of psychotropic treatment in pregnancy. DESIGN: Retrospective cohort studies. SETTING: Primary care. PARTICIPANTS: Women treated for psychosis who became pregnant, and their children. INTERVENTIONS: Treatment with antipsychotics, lithium or anticonvulsant mood stabilisers. MAIN OUTCOME MEASURES: Discontinuation and restarting of treatment; worsening of mental health; acute pre-eclampsia/gestational hypertension; gestational diabetes; caesarean section; perinatal death; major congenital malformations; poor birth outcome (low birthweight, preterm birth, small for gestational age, low Apgar score); transient poor birth outcomes (tremor, agitation, breathing and muscle tone problems); and neurodevelopmental and behavioural disorders. DATA SOURCES: Clinical Practice Research Datalink database and The Health Improvement Network primary care database. RESULTS: Prescribing of psychotropic medication was relatively constant before pregnancy, decreased sharply in early pregnancy and peaked after delivery. Antipsychotic and anticonvulsant treatment increased over the study period. The recording of markers of worsening mental health peaked after delivery. Pregnancy was a strong determinant for discontinuation of psychotropic medication. However, between 40% and 76% of women who discontinued psychotropic medication before or in early pregnancy restarted treatment by 15 months after delivery. The risk of major congenital malformations, and neurodevelopmental and behavioural outcomes in valproate (multiple manufacturers) users was twice that in users of other anticonvulsants. The risks of adverse maternal and child outcomes in women who continued antipsychotic use in pregnancy were not greater than in those who discontinued treatment before pregnancy. LIMITATIONS: A few women would have received parts of their care outside primary care, which may not be captured in this analysis. Likewise, the analyses were based on prescribing data, which may differ from usage. CONCLUSIONS: Psychotropic medication is prescribed before, during and after pregnancy. Many women discontinue treatment before or during early pregnancy and then restart again in late pregnancy or after delivery. Our results support previous associations between valproate and adverse child outcomes but we found no evidence of such an association for antipsychotics. FUTURE WORK: Future research should focus on (1) curtailing the use of sodium valproate; (2) estimating the benefits of psychotropic drug use in pregnancy; and (3) investigating the risks associated with lifestyle choices that are more prevalent among women using psychotropic drugs. FUNDING DETAILS: The National Institute for Health Research Health Technology Assessment programme
Fast and flexible selection with a single switch
Selection methods that require only a single-switch input, such as a button
click or blink, are potentially useful for individuals with motor impairments,
mobile technology users, and individuals wishing to transmit information
securely. We present a single-switch selection method, "Nomon," that is general
and efficient. Existing single-switch selection methods require selectable
options to be arranged in ways that limit potential applications. By contrast,
traditional operating systems, web browsers, and free-form applications (such
as drawing) place options at arbitrary points on the screen. Nomon, however,
has the flexibility to select any point on a screen. Nomon adapts automatically
to an individual's clicking ability; it allows a person who clicks precisely to
make a selection quickly and allows a person who clicks imprecisely more time
to make a selection without error. Nomon reaps gains in information rate by
allowing the specification of beliefs (priors) about option selection
probabilities and by avoiding tree-based selection schemes in favor of direct
(posterior) inference. We have developed both a Nomon-based writing application
and a drawing application. To evaluate Nomon's performance, we compared the
writing application with a popular existing method for single-switch writing
(row-column scanning). Novice users wrote 35% faster with the Nomon interface
than with the scanning interface. An experienced user (author TB, with > 10
hours practice) wrote at speeds of 9.3 words per minute with Nomon, using 1.2
clicks per character and making no errors in the final text.Comment: 14 pages, 5 figures, 1 table, presented at NIPS 2009 Mini-symposi
Structure-Guided Engineering of a Complement Component C3-Binding Nanobody Improves Specificity and Adds Cofactor Activity
The complement system is a part of the innate immune system, where it labels intruding pathogens as well as dying host cells for clearance. If complement regulation is compromised, the system may contribute to pathogenesis. The proteolytic fragment C3b of complement component C3, is the pivot point of the complement system and provides a scaffold for the assembly of the alternative pathway C3 convertase that greatly amplifies the initial complement activation. This makes C3b an attractive therapeutic target. We previously described a nanobody, hC3Nb1 binding to C3 and its degradation products. Here we show, that extending the N-terminus of hC3Nb1 by a Glu-Trp-Glu motif renders the resulting EWE-hC3Nb1 (EWE) nanobody specific for C3 degradation products. By fusing EWE to N-terminal CCP domains from complement Factor H (FH), we generated the fusion proteins EWEnH and EWEµH. In contrast to EWE, these fusion proteins supported Factor I (FI)-mediated cleavage of human and rat C3b. The EWE, EWEµH, and EWEnH proteins bound C3b and iC3b with low nanomolar dissociation constants and exerted strong inhibition of alternative pathway-mediated deposition of complement. Interestingly, EWEnH remained soluble above 20 mg/mL. Combined with the observed reactivity with both human and rat C3b as well as the ability to support FI-mediated cleavage of C3b, this features EWEnH as a promising candidate for in vivo studies in rodent models of complement driven pathogenesis
- …